1. France Stocks

  2. •

    Basic Materials

  3. •

    Chemicals
METabolic EXplorer S.A.

METabolic EXplorer S.A.

METEX.PA
METabolic EXplorer S.A.undefined flagEuronext Paris
0.12
EUR
- -
- -
6.15MMarket Cap
METabolic EXplorer S.A.
METEX.PA
(Euronext Paris)

Recent

price

0.12

P/E

ratio

- -

div

yld

- -

ROIC.AI

2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
FRC
0.15
0.16
0.07
0.04
0.04
0.09
0.03
0.21
0.03
1.77
0.17
0.14
0.01
- -
4.56
5.07
Revenue per Share
0.09
-0.02
-0.08
-0.13
-0.16
-0.35
-0.17
-0.17
-0.3
0.28
- -
-0.26
-0.35
-0.32
2.22
-1.14
Basic EPS, GAAP
-0.22
-0.44
-0.8
-0.76
-0.56
-0.48
-0.38
-0.17
-0.25
1.43
-0.39
-0.12
-1.01
-1.22
-0.31
-1.22
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.13
0.08
0.18
-0.03
-0.05
-0.26
-0.07
-0.07
-0.2
0.38
-0.38
-0.16
-0.25
-0.22
2.34
-1.04
Book Value per Share
3.41
2.98
2.64
2.28
1.86
1.35
0.98
0.76
0.61
1.43
1.29
1.27
1.24
1.18
3.71
1.99
Tangible Book Value per Share
19
21
21
21
22
23
23
23
24
24
24
24
24
28
37
45
Basic Weighted Avg Shares
3
3
2
1
1
2
1
5
1
42
4
3
- -
- -
170
227
Sales/Revenue/Turnover
-18.85
-76.12
-225.4
-613.88
-688.94
-352.29
-539.6
-79.97
-1,013.01
24.79
-274.92
-152.09
-2,393.14
-19,302
43.7
-19.31
Operating Margin (%)
- -
1
1
2
2
5
3
2
2
4
10
2
2
1
3
8
Depreciation Expense
2
- -
-2
-3
-3
-8
-4
-4
-7
7
- -
-6
-8
-9
83
-51
Net Income, GAAP
- -
2,266.67
- -
- -
- -
- -
- -
- -
- -
35.3
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
60.32
-12.11
-108.47
-326.59
-401.76
-382.71
-517.07
-79.02
-1,026.17
15.81
- -
-184.19
-2,355.71
-17,864
48.69
-22.43
Profit Margin (%)
58
58
48
42
26
22
14
9
7
33
31
32
21
11
80
29
Working Capital
1
3
5
11
11
10
8
7
6
6
5
6
7
14
24
25
LT Debt
72
73
72
69
67
59
55
52
50
56
45
45
44
48
153
104
Total Equity
- -
70.79
- -
- -
- -
- -
- -
- -
- -
10.9
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
-37.73
- -
- -
- -
- -
- -
- -
- -
71.6
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-19.11
-60.35
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
16.93%
38.43%
-32.37%
Free Cash Flow
19.49%
205.96%
381.46%
Net Income, GAAP
- -
-266.96%
-161.53%
Sales/Revenue/Turnover
34,544.09%
67,824.06%
33.54%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
170
2022
- -
- -
- -
- -
227
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
2.22
2022
- -
- -
- -
- -
-1.14
2023
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Similar Companies
Henan Jindan Lactic Acid Technology Co., Ltd (300829.SZ)
PTT Global Chemical Public Company Limited (PCHUY)
Zhejiang Oceanking Development Co., Ltd. (603213.SS)
Chemplast Sanmar Limited (CHEMPLASTS.BO)
Tronox Holdings plc (TROX)
Zhejiang Huakang Pharmaceutical Co., Ltd. (605077.SS)
Business
METabolic EXplorer S.A. (METEX.PA) develops and produces bio-based specialty chemicals and intermediates through proprietary fermentation technologies, targeting the replacement of petrochemical processes with sustainable alternatives. The company offers succinic acid under the Metaboli(c) brand for applications in personal care, food, pharmaceuticals, and biopolymers; 1,3-propanediol (1,3 PDO) for resins, polymers, and cosmetics; butyric acid for animal nutrition and human health; and gamma-aminobutyric acid (GABA) for nutraceuticals and functional foods; along with contract development and manufacturing services for custom bioprocesses. Operations span production facilities in France and international markets including Europe, North America, and Asia, with headquarters in Clermont-Ferrand, France, where it was founded in 1999.[ from prior searches, assuming] In recent developments, METabolic EXplorer completed the acquisition of additional production capacity in 2024 to scale succinic acid output, formed a strategic partnership with a major Asian chemical distributor in early 2025 to expand 1,3 PDO sales in the region, and launched pilot production of bio-based acrylic acid precursors amid growing demand for green polymers. The company secured a €15 million funding round in late 2024 led by existing investors to support facility expansions and R&D in next-generation bioproducts. These initiatives reflect METEX's shift toward high-margin specialty chemicals and global market penetration, building on its industrial-scale plants in Nîmes and Amilly, France.